FN-1501
- Generic Name
- FN-1501
- Brand Names
- Cellcept, Myfenax, CellCept, Mycophenolate mofetil Teva, Myclausen
- Drug Type
- Small Molecule
- Chemical Formula
- C22H25N9O
- CAS Number
- 1429515-59-2
- Unique Ingredient Identifier
- 6MC966B505
- Background
Mycophenolate mofetil, also known as MMF or CellCept, is a prodrug of mycophenolic acid, and classified as a reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). This drug is an immunosuppressant combined with drugs such as Cyclosporine and corticosteroids to prevent organ rejection after hepatic, renal, and cardiac transplants. It is markete...
- Indication
Mycophenolate mofetil is indicated in combination with other immunosuppressants to prevent the rejection of kidney, heart, or liver transplants in adult and pediatric patients ≥3 months old. Mycophenolate mofetil may also be used off-label as a second-line treatment for autoimmune hepatitis that has not responded adequately to first-line therapy. Other off-l...
- Associated Conditions
- Transplanted Organ Rejection
- Associated Therapies
- -
A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation
- Conditions
- Interventions
- First Posted Date
- 2002-10-25
- Last Posted Date
- 2016-06-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 434
- Registration Number
- NCT00048165
A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection
- Conditions
- First Posted Date
- 2002-05-30
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 56
- Registration Number
- NCT00038272
- Locations
- 🇺🇸
Beth Israel Med. Ctr., ACTU, New York, New York, United States
🇺🇸Hosp. of the Univ. of Pennsylvania CRS, Philadelphia, Pennsylvania, United States
🇺🇸UC Davis Medical Center, Sacramento, California, United States
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
- Conditions
- First Posted Date
- 2002-01-11
- Last Posted Date
- 2016-07-29
- Target Recruit Count
- 30
- Registration Number
- NCT00029380
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸Children's Hospital, Oakland, Oakland, California, United States
🇺🇸Children's National Medical Center, Washington, District of Columbia, United States
Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment
- Conditions
Pediatric Kidney Transplant Without Calcineurin Inhibitors
- Conditions
- Interventions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2016-10-21
- Target Recruit Count
- 35
- Registration Number
- NCT00023231
- Locations
- 🇺🇸
Lauren Schenker, Rockville, Maryland, United States
Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders
- Conditions
- First Posted Date
- 2001-02-02
- Last Posted Date
- 2014-12-09
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00010361
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
- Conditions
- Interventions
- First Posted Date
- 2001-01-08
- Last Posted Date
- 2019-07-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT00008450
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation
- Conditions
- First Posted Date
- 2000-12-07
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 20
- Registration Number
- NCT00007059
- Locations
- 🇺🇸
University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
- Conditions
- First Posted Date
- 2000-07-07
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 130
- Registration Number
- NCT00005935
- Locations
- 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
- Conditions
- First Posted Date
- 2000-02-14
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 75
- Registration Number
- NCT00004567
- Locations
- 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.